LMAT Form 144: Director sold 8,464 shares

LMAT insider sale disclosure: A Form 144 lists a reported sale of 8,464 shares of Common Stock by David B. Roberts on 02/27/2026 for $903,957.00.

Rhea-AI Filing Summary

LMAT insider sale disclosure: A Form 144 lists a reported sale of 8,464 shares of Common Stock by David B. Roberts on 02/27/2026 for $903,957.00. The filing also lists 3,312 Common shares tied to equity compensation (stock option exercises and RSUs) dated 12/02/2024.

Insights

Corporate Governance / Insider Transactions

Routine insider sale disclosed; transaction size and compensation-related shares are listed.

The filing shows a reported sale by David B. Roberts of 8,464 Common shares on 02/27/2026 with proceeds listed as $903,957.00. The record also lists 3,312 Common shares tied to equity compensation dated 12/02/2024.

These entries are transactional disclosures rather than corporate actions; timing and cash‑flow treatment beyond the listed proceeds are not included in the excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the LMAT Form 144 disclose about insider transactions?

The Form 144 discloses a sale of 8,464 Common shares by David B. Roberts on 02/27/2026 for $903,957.00. It also lists 3,312 shares tied to equity compensation dated 12/02/2024.

Who reported the share sale in the LMAT filing?

The filing identifies David B. Roberts as the reporting party. The entry lists the security as Common stock and shows the transaction date as 02/27/2026 and proceeds as $903,957.00.

Does the Form 144 show shares from equity compensation for LMAT?

Yes. The filing lists 3,312 Common shares described as resulting from "Stock Option Exercises and Stock Grants RSUs" with an associated date of 12/02/2024.

Are proceeds from the disclosed sale shown in the LMAT Form 144?

Yes. The sale by David B. Roberts on 02/27/2026 shows proceeds of $903,957.00 tied to the reported 8,464 shares sold, as listed in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/11/2026 - 11:28 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001365731
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	LEMAITRE VASCULAR INC
SEC File Number	001-33092
Address of Issuer	63 SECOND AVENUE BURLINGTON MASSACHUSETTS 01803
Phone	781-221-2266
Name of Person for Whose Account the Securities are To Be Sold	Roberts David B
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab Corp 3000 Schwab Way Westlake TX 76262	3312	357893.00	22778363	03/11/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/02/2024	Various: Stock Option Exercises and Stock Grants RSUs	Issuer			3312	12/02/2024	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David B. Roberts 63 Second Avenue Burlington MA 01803	Common	02/27/2026	8464	903957.00

144: Remarks and Signature

Remarks	1. Shareholder/Client's account is registered: David B Roberts TTEE David B Roberts 2003 Trust 2. Shareholder/Client's is selling whole shares and fractional shares totaling: 3,311.6789 shares of LMAT 3. Shareholder/Client acquired shares in various dates from 12/2/2024 thru 3/10/2025
Date of Notice	03/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	David B. Roberts
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)